risperidone has been researched along with Atherogenesis in 1 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We examined 42 patients with paranoid schizophrenia." | 1.42 | [Lipid spectrum changes and ECG in patients with paranoid schizophrenia in the course of therapy with atypical antipsychotics]. ( Borodyuk, YN; Burdovitsina, TG; Kornetova, EG; Parshukova, DA; Semke, AV; Seregin, AA; Smirnova, LP; Tkacheva, GD, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smirnova, LP | 1 |
| Parshukova, DA | 1 |
| Borodyuk, YN | 1 |
| Kornetova, EG | 1 |
| Tkacheva, GD | 1 |
| Seregin, AA | 1 |
| Burdovitsina, TG | 1 |
| Semke, AV | 1 |
1 other study available for risperidone and Atherogenesis
| Article | Year |
|---|---|
[Lipid spectrum changes and ECG in patients with paranoid schizophrenia in the course of therapy with atypical antipsychotics].
Topics: Adult; Antipsychotic Agents; Atherosclerosis; Benzodiazepines; Dibenzothiazepines; Electrocardiograp | 2015 |